Movement Disorders

Movement Disorders

Why narcolepsy should not be considered an autoimmune disorder 7:19
Why narcolepsy should not be considered an autoimmune disorder
Angela Vincent • 30 Oct 2020
Deep brain stimulation: benefits for both motor and non-motor symptoms 1:57
Deep brain stimulation: benefits for both motor and non-motor symptoms
Keyoumars Ashkan • 31 Oct 2020
Treating pediatric neuropsychiatric conditions with DBS 2:31
Treating pediatric neuropsychiatric conditions with DBS
Keyoumars Ashkan • 31 Oct 2020
The advantages of deep brain stimulation for Parkinson’s disease 1:02
The advantages of deep brain stimulation for Parkinson’s disease
Abdelhamid Benazzouz • 30 Oct 2020
Deep brain stimulation for dystonia 1:49
Deep brain stimulation for dystonia
Keyoumars Ashkan • 31 Oct 2020
Impact of COVID-19 on neurological disorders 1:32
Impact of COVID-19 on neurological disorders
Elena Moro • 22 Sep 2020
Treatment options for dystonia: anticholinergics, levodopa, botulinum toxin and DBS 3:57
Treatment options for dystonia: anticholinergics, levodopa, botulinum toxin and DBS
Susanne Schneider • 17 Sep 2020
MDS-European Section: education portfolio 3:02
MDS-European Section: education portfolio
Cristian Falup-Pecurariu • 22 Sep 2020
COVID-19 neurological manifestations: short and long-term 3:24
COVID-19 neurological manifestations: short and long-term
Elena Moro • 22 Sep 2020
Challenges in diagnosing and treating dystonia 2:08
Challenges in diagnosing and treating dystonia
Susanne Schneider • 17 Sep 2020
Deep brain stimulation as an effective treatment for Parkinson’s disease, dystonia and tremor 3:21
Deep brain stimulation as an effective treatment for Parkinson’s disease, dystonia and tremor
Elena Moro • 22 Sep 2020
The importance of genetic testing for diagnosing and treating dystonia 1:40
The importance of genetic testing for diagnosing and treating dystonia
Susanne Schneider • 17 Sep 2020
Dystonia: developments in diagnostics, genetics and treatment 2:49
Dystonia: developments in diagnostics, genetics and treatment
Susanne Schneider • 17 Sep 2020
Education on remote patient care in response to the COVID-19 pandemic 1:17
Education on remote patient care in response to the COVID-19 pandemic
Cristian Falup-Pecurariu • 22 Sep 2020
Peripheral α-synuclein as a Parkinson’s disease biomarker 4:00
Peripheral α-synuclein as a Parkinson’s disease biomarker
Charles H. Adler • 10 Sep 2020
Challenges and good outcomes with telemedicine during COVID-19 2:27
Challenges and good outcomes with telemedicine during COVID-19
Alfonso Fasano • 16 Sep 2020
The content of VJNeurology is intended for healthcare professionals